Ryman Healthcare Statistics

Total Valuation

FRA:RH7 has a market cap or net worth of EUR 1.15 billion. The enterprise value is 2.03 billion.

Market Cap	1.15B
Enterprise Value	2.03B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.01B
Shares Outstanding	n/a
Shares Change (YoY)	+3.28%
Shares Change (QoQ)	+6.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	987.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	20.91
PS Ratio	2.90
PB Ratio	0.52
P/TBV Ratio	0.52
P/FCF Ratio	8.64
P/OCF Ratio	5.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.86
EV / Sales	5.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	15.19

Financial Position

The company has a current ratio of 0.04, with a Debt / Equity ratio of 0.40.

Current Ratio	0.04
Quick Ratio	0.01
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	6.72
Interest Coverage	-0.23

Financial Efficiency

Return on equity (ROE) is -10.91% and return on invested capital (ROIC) is -0.41%.

Return on Equity (ROE)	-10.91%
Return on Assets (ROA)	-0.21%
Return on Invested Capital (ROIC)	-0.41%
Return on Capital Employed (ROCE)	-0.66%
Revenue Per Employee	51,696
Profits Per Employee	-29,747
Employee Count	7,700
Asset Turnover	0.06
Inventory Turnover	626.17

Taxes

In the past 12 months, FRA:RH7 has paid 116.11 million in taxes.

Income Tax	116.11M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.96%
50-Day Moving Average	1.19
200-Day Moving Average	1.97
Relative Strength Index (RSI)	42.64
Average Volume (20 Days)	3,472

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:RH7 had revenue of EUR 398.06 million and -229.05 million in losses. Loss per share was -0.32.

Revenue	398.06M
Gross Profit	4.23M
Operating Income	-21.18M
Pretax Income	-112.94M
Net Income	-229.05M
EBITDA	-2.83M
EBIT	-21.18M
Loss Per Share	-0.32

Full Income Statement

Balance Sheet

The company has 9.99 million in cash and 896.94 million in debt, giving a net cash position of -886.96 million.

Cash & Cash Equivalents	9.99M
Total Debt	896.94M
Net Cash	-886.96M
Net Cash Per Share	n/a
Equity (Book Value)	2.23B
Book Value Per Share	2.20
Working Capital	-2.99B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 215.11 million and capital expenditures -81.58 million, giving a free cash flow of 133.53 million.

Operating Cash Flow	215.11M
Capital Expenditures	-81.58M
Free Cash Flow	133.53M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 1.06%, with operating and profit margins of -5.32% and -57.54%.

Gross Margin	1.06%
Operating Margin	-5.32%
Pretax Margin	-28.37%
Profit Margin	-57.54%
EBITDA Margin	-0.71%
EBIT Margin	-5.32%
FCF Margin	33.54%

Dividends & Yields

FRA:RH7 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.28%
Shareholder Yield	n/a
Earnings Yield	-19.85%
FCF Yield	11.57%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:RH7 has an Altman Z-Score of -0.03 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.03
Piotroski F-Score	5